CAS RN: 1345974-63-1

Tetrakis[(S)-(+)-[(1S)-1-(4-broMophenyl)-2,2-diphenylcyclopropanecarboxylato]dirhodiuM(II) Rh2(S-BTPCP)4

Product Availability

Choose a grade to view its available package options.

7 package records6 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260426 50mg / 100mg / 250mg Out of stock 8-10 business days Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260416 100mg In stock Shanghai Inquiry
Batchno.20251227 10mg In stock Shanghai Inquiry
Batchno.20250215 1g In stock Shanghai Inquiry
Batchno.20250920 250mg In stock Shanghai Inquiry
Batchno.20251204 25mg In stock Shanghai Inquiry
Batchno.20260624 50mg In stock Shanghai Inquiry
  • Product code: starshine_CAS1345974-63-1
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1345974-63-1 / tetrakis((1S)-1-(4-bromophenyl)-2,2-diphenylcyclopropane-1-carboxylate);bis(rhodium(2+))

Standard CAS: 1345974-63-1 Multi CAS: No

Basic Information

CAS
1345974-63-1
Multi CAS
No
Molecular Formula
C88H64Br4O8Rh2
Molecular Weight
1774.900000
Exact Mass
1773.940360
SMILES
C1[C@@](C1(C2=CC=CC=C2)C3=CC=CC=C3)(C4=CC=C(C=C4)Br)C(=O)[O-].C1[C@@](C1(C2=CC=CC=C2)C3=CC=CC=C3)(C4=CC=C(C=C4)Br)C(=O)[O-].C1[C@@](C1(C2=CC=CC=C2)C3=CC=CC=C3)(C4=CC=C(C=C4)Br)C(=O)[O-].C1[C@@](C1(C2=CC=CC=C2)C3=CC=CC=C3)(C4=CC=C(C=C4)Br)C(=O)[O-].[Rh+2].[Rh+2]
InChI
InChI=1S/4C22H17BrO2.2Rh/c4*23-19-13-11-18(12-14-19)22(20(24)25)15-21(22,16-7-3-1-4-8-16)17-9-5-2-6-10-17;;/h4*1-14H,15H2,(H,24,25);;/q;;;;2*+2/p-4/t4*22-;;/m1111../s1
InChIKey
AUKMNKVXIVVWIG-MSZWWGBCSA-J

Computed Properties

Structural Parameters

Heavy atom count
102
Aromatic heavy atom count
72
Fraction Csp3
0.14
Rotatable bonds
16
H-bond acceptors
8
Molar refractivity
396.43
TPSA
160.52

LogP / Solubility

WLOGP
15.3
MLOGP
13.65
XLogP3
15.3
Consensus LogP
14.75
Log S (ESOL)
-19.95
Class (ESOL)
Insoluble
Log S (Ali)
-25.16
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-25.82
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.68

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
10

Safety & Transport

Pictogram(s)
Irritant
Signal
Warning
GHS Hazard Statements
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
Precautionary Statement Codes
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501

Get In Touch

Contact Us